January 24, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on the Centers for Medicare & Medicaid Services (CMS) report regarding direct and indirect remuneration (DIR) in Medicare Part D:
“CMS’s report highlights how DIR reduces premiums for Medicare Part D beneficiaries, which leads to lower costs for the federal government. Stable and affordable premiums contribute to a 90% satisfaction rate among Part D enrollees for their drug plan.
We look forward to working with the new Administration, congressional leaders and other stakeholders to ensure that the competitive Part D model remains affordable and successful in the years to come.”